Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN11 | Q06124 | 5/20 | 0.42 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.40 |
| ▸ | PTPN6 | P29350 | 1/20 | 0.40 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.40 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.40 |
| ▸ | THRA | P10827 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | MCHR1 | Q99705 | 2/20 | 0.39 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.39 |
| ▸ | BCHE | P06276 | 1/20 | 0.38 |
| ▸ | ACHE | P22303 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17465202 | 0.93 | S1PR1 (0.45) | PTPN11PTPN1PTPN6S1PR1SMPD1 | |
| SCHEMBL6737580 | 0.90 | PTPN11 (0.44) | PTPN11PTPN1PTPN6SMPD1MCHR1 | |
| SCHEMBL30475756 | 0.82 | NR5A1 (0.49) | — | |
| SCHEMBL28252092 | 0.82 | NR5A1 (0.49) | — | |
| SCHEMBL14182502 | 0.82 | NR5A1 (0.49) | — | |
| SCHEMBL14182510 | 0.82 | NR5A1 (0.49) | — | |
| SCHEMBL30398576 | 0.80 | TSHR (0.50) | PTPN11SMPD1 | |
| SCHEMBL15158960 | 0.80 | TSHR (0.50) | PTPN11SMPD1 | |
| SCHEMBL2856448 | 0.79 | PTPN11 (0.55) | PTPN11PTPN1PTPN6SMPD1 | |
| SCHEMBL13957128 | 0.79 | PTPN11 (0.55) | PTPN11PTPN1PTPN6SMPD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009126118-A1 | UNIQUE PROCESSABLE GREEN POLYMER WITH A TRANSMISSIVE OXIDIZED STATE FOR REALIZATION OF COMMERICAL RGB BASED ELECTROCHROMIC DEVICE APPLICATIONS | TOPPARE LEVENT KAMIL (TR) | 2009-10-15 | — | — | WO | claimed |
| US-8324400-B2 | Benzotriazole containing donor-acceptor type polymer as a multi-purpose material | TOPPARE LEVENT KAMIL (TR) | 2012-12-04 | — | — | US | disclosed |
| US-20120083583-A1 | BENZOTRIAZOLE CONTAINING DONOR-ACCEPTOR TYPE POLYMER AS A MULTI-PURPOSE MATERIAL | TOPPARE LEVENT KAMIL (TR) | 2012-04-05 | — | — | US | disclosed |
| WO-2010114497-A1 | BENZOTRIAZOLE CONTAINING DONOR-ACCEPTOR TYPE POLYMER AS A MULTI-PURPOSE MATERIAL | TOPPARE LEVENT KAMIL (TR) | 2010-10-07 | — | — | WO | disclosed |
| US-20100249367-A1 | BENZOTRIAZOLE CONTAINING DONOR-ACCEPTOR TYPE POLYMER AS A MULTI-PURPOSE MATERIAL | TOPPARE LEVENT KAMIL | 2010-09-30 | — | — | US | disclosed |
| WO-2009126118-A1 | UNIQUE PROCESSABLE GREEN POLYMER WITH A TRANSMISSIVE OXIDIZED STATE FOR REALIZATION OF COMMERICAL RGB BASED ELECTROCHROMIC DEVICE APPLICATIONS | TOPPARE LEVENT KAMIL (TR) | 2009-10-15 | — | — | WO | disclosed |
| WO-2009126118-A1 | UNIQUE PROCESSABLE GREEN POLYMER WITH A TRANSMISSIVE OXIDIZED STATE FOR REALIZATION OF COMMERICAL RGB BASED ELECTROCHROMIC DEVICE APPLICATIONS | TOPPARE LEVENT KAMIL (TR) | 2009-10-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100249367-A1 | BENZOTRIAZOLE CONTAINING DONOR-ACCEPTOR TYPE POLYMER AS A MULTI-PURPOSE MATERIAL | TYR, AADAT, BHMT2 | PTPN11 1398/4885PTPN1 3415/4885PTPN6 2687/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.